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1. Executive!Summary!
In this report we describe the past and planned future workshops for the rare disease 
(RD) domain within the context of the ELIXIR-EXCELERATE project with the aims (1) to 
identify key training contacts/subjects in the RD community, (2) to identify specific training 
needs in the RD community and (3) to spread specific knowledge needed in the RD 
community. An important mission of EXCELERATE WP8 ‘ELIXIR infrastructure for Rare 
Disease research’, defined at the kick-off meeting on November 24, 2015 in Leiden, is to 
help the rare disease community in different nodes to raise its infrastructure activities to 
the level of best practices in ELIXIR infrastructure, i.e. where rare disease data, metadata, 
tools, and catalogues are shared, interoperable, and sustainable at the source, conform a 
common set of principles and standards across participating countries/nodes and in 
agreement with the ELIXIR platforms. To achieve optimal knowledge exchange between 
the domains, workshops in this WP are typically co-organised with members from the rare 
disease community and co-sponsored by relevant projects such as RD-Connect . 
Events were either organised specifically with the Rare Disease (RD) community, or a 
separate stream/session for the RD community was co-organised around other events. 
Training workshops and courses were delivered in partnership with WP11 ‘EXCELERATE 
Training Programme’. 
The delivery of workshops was complemented by the ELIXIR implementation study/RD-
Connect proof-of-concept to test interoperability backbone components for enabling 
queries across rare disease biobanks and registries. 
 
2. Project!objectives!
With this deliverable, the project has reached or the deliverable has contributed to the 
following objectives: 
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No.$ Objective$ Yes$ No$
1! Build the ELIXIR registry of data resources and analysis tools 
critical for the development of the rare disease research. (Task 
8.1) 
 x 
2! Continuous monitoring of resources and tools in Rare-diseases.  x 
3! Implementation of a system for the generation of datasets 
adequate for the assessment of methods in the area of rare- 
diseases. 
 x 
4! Implementation of the ELIXIR rare-disease portfolio in the ELIXIR 
registry. 
 x 
5! Implementation of a technical framework for the comparison and 
standardization of services useful for the rare-disease 
communities. (Task 8.2) 
 x 
6! Collaboration with the rare-disease communities for the 
organization of training courses, workshops and jamborees. (Task 
8.3) 
x  
3. Delivery!and!schedule!
The delivery is delayed: ! Yes " No 
4. Adjustments!made!
No adjustments were made. 
 
5. Background!information!
Background information on this WP as originally indicated in the description of action 
(DoA) is included here for reference. 
 
Work package number  8 Start date or starting event: month 1 
Work package title Use Case C: ELIXIR infrastructure for Rare Disease research 
Lead Ivo Gut (ES) and Marco Roos (NL) 
Participant number and person months per participant 
4 – UNIMAN 6.00, 6 – NBIC 0.00, LUMC 6.00, 7 – CNIO 10.00, 8 – CRG 38.40, 10 – IRB 
12.00, 12 – BSC 10.00, 22 – NTNU 12.00, 26 – CNRS 12.00, 30 – CNR 3.00, 32 – UL 
15.00, 38 – DTU 12.00 
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The International Rare Diseases Research Consortium (http://www.irdirc.org) established 
the ambitious goal of developing 200 new therapies by 2020. ELIXIR as a whole and in 
particular this Work Package is aligned with this effort. The overall objective of this Work 
Package (WP) is to address the needs of the rare diseases community through the 
instantiation of the ELIXIR resources described in WP1-5. These resources do not 
constitute a replacement of the current research projects organized around the rare 
diseases area. Indeed the aim is to empower them and to help in the sustainability of the 
resources created by these projects in the long term. 
Work Package Lead: Ivo Gut (ES) and Marco Roos (NL) 
Objectives!
WP8 aims to empower actors involved in the development of new rare diseases 
therapies through the execution of the following specific objectives: 
• Build the ELIXIR registry of data resources and analysis tools critical for the 
development of the rare disease research. (Task 8.1) 
• Continuous monitoring of resources and tools in Rare-diseases. 
• Implementation of a system for the generation of datasets adequate for the 
assessment of methods in the area of rare- diseases. 
• Implementation of the ELIXIR rare-disease portfolio in the ELIXIR registry. 
• Implementation of a technical framework for the comparison and standardization 
of services useful for the rare-disease communities. (Task 8.2) 
• Collaboration with the rare-disease communities for the organization of training 
courses, workshops and jamborees. (Task 8.3) 
Description of work and role of partners 
This WP is organised around the actors that play a major role on the development of 
these new therapies. These actors are the main users of the ELIXIR infrastructure: data 
generators and curators (usually personnel working in hospitals, genomics-based 
companies, and members of large research consortia), researchers (bioinformaticians, 
geneticists, and clinical doctors), diagnosis companies, CROs (usually SMEs), and the 
pharmaceutical industry among others 
Task 8.1: The ELIXIR portfolio of data resources developed in collaboration with 
the rare diseases communities. (69.4PM) 
Subtask 8.1.1 Monitoring of resources and tools. (25.4PM) 
There is a wide range of data resources and analysis methods used in the rare-disease 
area. Many of those resources are provided by ELIXIR Nodes, for example the European 
Genome-Phenome archive (EGA) currently stores data from major research initiatives in 
rare diseases like the RD-connect project. In this subtask we will review the current data 
resources and evaluate their usability and potential impact on the rare disease 
community. An important aspect of the evaluation will be the security of the data that is a 
key aspect in rare disease domain given the low frequency of the associated genomic 
variants in the population. 
One critical aspect of the development of the registry is to engage the different 
communities in the submission and rating of the tools. In this task we will work together 
with representatives of the major projects in the field of rare- diseases to create a 
customized portfolio of ELIXIR tools and services devoted to assist them in the 
development of these new therapies. As an example we will ask for proposals of tools 
that serve to interpret the effect of genomics variants on a group of patients that belong 
to the same family. We strongly believe that this link between the end- users and the 
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tools developers will help ELIXIR to understand better the problems that are actually 
facing the main actors in the rare diseases research and hence to better solutions. 
The final outcome of this task will be the ELIXIR data resources and analysis tools useful 
to the rare disease communities. 
Partners: NO, ES, SI, IT, NL 
Subtask 8.1.2: Creation of reference datasets adequate for the specific assessment of 
methods and standards in the area of rare-diseases. (30PM) 
While the creation of these tools should stay as a priority for researchers, large scale 
projects, SMEs and the industry increasingly need access to benchmarked methods on 
which to build their analysis strategies. 
The evaluation of the methods requires the adequate selection of the datasets and 
benchmarking strategies. The systems for the selection of the datasets for the 
benchmarking have to be fast and effective to enable the continuous evaluation of the 
methods, as described in WP2. We will collaborate with the ELIXIR benchmarking 
strategy (WP2) to build the appropriate strategies for the selection of the datasets 
(subtask 8.1.1 above) and with the rare- disease communities to implement the adequate 
quality reporting standards. Moreover we will integrate these pipelines in the ELIXIR 
benchmarking framework (WP2) to continuously monitor the selected methods with the 
newly generated datasets. Partners: ES, DK, IT,FR, SI, UK 
Subtask 8.1.3 Implementation of the ELIXIR rare-disease portfolio in the ELIXIR registry. 
(14PM) 
The ELIXIR registry will be a reference for the research community (WP1), as it will 
reflect the quality and the real- time status of the services included on it. This registry will 
act as a one-stop shop for services provided by ELIXIR. The goal is to allow users from 
the different countries, communities and projects to discover which are the tools available 
at a given time, with the associated information about the community based rating (see 
WP2), instructions for correct use and associated examples We will encourage tools 
developers to adopt the EDAM standard to describe their tools and to share several 
metrics about the performance and usage of these of the tools (see description in WP1) 
Those services promoted as relevant by the end-users will be listed in a special section 
in the ELIXIR registry. Partners: DK, ES, FR. 
Task 8.2: Standardisation of rare disease services in collaboration with the RD 
communities. (36PM) 
The ecosystem of RD services will inevitably be a combination of distributed and 
centralized resources, because of the sheer number of rare diseases and rare disease 
organisations, as well as legal and ethical constraints between countries and 
communities. At the same time, because of the low frequency in the population, 
combining data across patient registries, biobanks, and -omics databases is the single 
most important way of getting new insights towards new treatments. 
One of the most recurrent issues when attempting to perform research across resources 
is the lack of standards or the poor adoption of existing standards by RD stakeholders. 
Rare disease standards concern different types of data including genomic and 
phenotypic characteristics, causative genetic variation status, quality criteria, analysis 
protocols, supporting evidence and follow-up indicators. These problems will be analysed 
in workshops including experts in semantic web, linked data technologies and rare-
disease experts (see previous experiences and proposal in “Bring Your Own Data 
(BYOD) bootcamps”, in WP5). The initial experience with this methodology (see 61) is 
that a critical bottleneck is the identification of the most appropriate terms and identifiers 
to annotate data for cross- resource questions. Based on this experience we aim to 
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address two major 'white spots' in the available infrastructure for Rare-diseases: (i) the 
current infrastructure of the rare disease platform: RD-Connect, does not contain 
backbone services for functional interlinking, (ii) a majority of RD sources are not 
equipped to provide data, metadata, and data updates using appropriate standard 
procedures. To address these needs we will work together with WP5, the rare-disease 
communities and the RD-Connect project to (i) deploy and test the services and 
guidelines for standardization 'at the source', (ii) provide standardized interfaces that 
Rare-disease communities can work with from a central location, (iii) build capacity in the 
RD community by enabling them to work with these services themselves. 
Partners: FR, ES, DK, NL. 
Task 8.3: Training workshops targeting different user communities. (32PM) 
In this task training workshops and courses will be delivered, in partnership with WP11 
“EXCELERATE Training Programme”. The training will be approached from two sides. 
First, in collaboration with the Train the Researcher task in WP11 we will train rare 
diseases’ researchers in the use of relevant tools, standards and infrastructure produced 
by ELIXIR. Second, we will run “feedback workshops” in which those who are developing 
the methods will be exposed directly to problems faced by the rare disease community. 
These userthons will help to shape the ELIXIR portfolio. The direct collaboration with 
WP11 Train the Researcher will ensure that researchers are trained to a high standard in 
state-of-the-art analysis techniques for rare disease data and that innovative training 
approaches developed in this task are applied elsewhere in ELIXIR. 
Partners: UK, SI, NL 
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Summary!
In this report we describe the past and planned future workshops for the rare disease 
(RD) domain within the context of the ELIXIR-EXCELERATE project with the aims 
(1) to identify key training contacts/subjects in the RD community, (2) to identify 
specific training needs in the RD community and (3) to spread specific knowledge 
needed in the RD community. An important mission of EXCELERATE WP8 ‘ELIXIR 
infrastructure for Rare Disease research’, defined at the kick-off meeting on 
November 24, 2015 in Leiden, is to help the rare disease community in different 
nodes to raise its infrastructure activities to the level of best practices in ELIXIR 
infrastructure, i.e. where rare disease data, metadata, tools, and catalogues are 
shared, interoperable, and sustainable at the source, conform a common set of 
principles and standards across participating countries/nodes and in agreement with 
the ELIXIR platforms. To achieve optimal knowledge exchange between the 
domains, workshops in this WP are typically co-organised with members from the 
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rare disease community and co-sponsored by relevant projects such as RD-
Connect1. 
Events were either organised specifically with the Rare Disease (RD) community, or 
a separate stream/session for the RD community was co-organised around other 
events. Training workshops and courses were delivered in partnership with WP11 
‘EXCELERATE Training Programme’. 
The delivery of workshops was complemented by the ELIXIR implementation 
study/RD-Connect proof-of-concept to test interoperability backbone components for 
enabling queries across rare disease biobanks and registries. 
 
  
                                                
1 http://rd-connect.eu/ 
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1. Workshops!for!and!with!the!rare!disease!
community!
EXCELERATE members contribute to the workshops by advising in rare disease 
workshops, mediating them and organising the contribution of data experts, such as 
in the case of Bring Your Own Data events - BYODs (contributions of Marco Roos 
and Mascha Jansen for ELIXIR-NL). Based on the experience from the workshops, 
they take initiatives towards collaboratively developing protocols and tooling (e.g. the 
rare disease data linkage plan co-led by EXCELERATE WP8 co-lead Marco Roos), 
define new training goals (led by Brane Leskosek and Celia van Gelder for WP8/11), 
and further developing the Rare Disease Connect platform (led by WP8 co-leads Ivo 
Gut and Sergi Beltran). The objectives of the contributions are: (i) to stimulate and 
foster rare disease data resources to become FAIR at the source (Findable, 
Accssible, Interoperable, Reusable for humans and computers), (ii) to stimulate the 
rare disease community to share (meta)data via the RD-Connect platform and 
European infrastructures such as EGA. Below is a description of five specific 
workshops organised within the RD domain (Table 1). 
 
TABLE 1: LIST OF WORKSHOPS AND EVENTS 
Nr. Place Date Event Participa
nts 
Parti-
cipants 
Topic 
1 Rome, IT 24–25 Sep 
2015 
RD-Connect 
workshop data 
linkage and 
ontologies  
NL, IT, 
UK, AT, 
EL, ES, 
DE, FR, 
RO 
23 Hands-on tutorial 
for (aspiring) 
managers of rare 
disease registries. 
2 Utrecht, 
NL 
30 Nov–4 
Dec 2015 
Managing and 
Integrating Life 
Science 
Information 
IT, NL, 
SI, UK, 
EBI 
10 Managing large, 
heterogeneous 
(FAIR) data 
sources (including 
RD sources) with 
exploitation 
principles. 
3 Barcelona, 
ES 
8 Mar 2016 ELIXIR All-
Hands 
all ELIXIR 
members 
+ AT 
20+ ELIXIR and RD-
Connect 
workshop. 
4 Helsinki, FI 13-15 June 
2016 
Variant Analysis 
Workshop 
FI, ES, 
FR, EBI, 
EE, DE 
43 ELIXIR and RD-
Connect 
workshop. 
5 Rome, IT 27-29 Jul 
2016 
Next generation 
registries: going 
FAIR, going 
Gold 
NL, IT, 
UK, AT, 
EL, ES, 
DE, FR, 
RO, USA  
21 (+5 
remote 
connectio
n) 
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1.1. Data!linkage!and!ontologies!
Collaborative workshop with RD-Connect 
Rome, 24–25 September 2015 
 
From 2014 onwards, BYODs and their follow-up have played an important role for 
the collaborative, cross-project endorsement of interoperable data infrastructure for 
the rare disease domain. ELIXIR members have contributed significantly to the 
success of these workshops. In this particular event, also coined ‘a BYOD for 
beginners’, stakeholders who manage a disease registry or were planning to create a 
new rare disease registry were introduced to an approach that prepares data for 
cross-resource analysis via uniform resource identifiers and ontologies. Via a simple 
tutorial they simulated enabling questions across federated multi-lingual registries. 
Participants created mock registries and from them a mock catalogue to answer 
basic questions. First, a traditional approach was used based on merging tables and 
then an approach was used based on using ontological concepts and Linked Data. It 
showed how problems caused by ambiguity of terms and language differences can 
be mitigated by using stardardised, computer-readable identifiers that are linked to 
ontologies. The guided hands-on session was preceded by introductory lectures on 
data linkage basics (M. Roos; LUMC/ELIXIR-NL), application ontologies (S. 
Sarntivijai; EBI), and WikiData (A. Waagmeester; Micelio). 
The event (http://www.iss.it/cnmr/?lang=1&id=2585&tipo=3 ) was held on the two 
days following an annual summer school organised by ISS2. The meeting was 
organised in collaboration with the RD-Connect linked data and ontologies task force 
(http://rd-connect.eu/platform/registries/linked-data-and-ontology-task-force/ ), the 
Leiden University Medical Center (http://www.lumc.nl), ELIXIR (https://www.elixir-
europe.org/ ), and ELIXIR-NL/DTL (http://www.dtls.nl/ ). 
The event was following the aim of delivering specific knowledge to the RD 
community to raise capacity of the participants. 
1.2. Managing!and!Integrating!Life!Science!Information!
Collaborative BioSB/RD-Connect/ELIXIR-NL Course 
Utrecht, 30 November–4 December 2015 
 
At the 4th edition of this course, which is part of the BioSB course portfolio 
(www.biosb.nl), new techniques for working with large, heterogeneous data sources 
were shown together with the principles on how to exploit existing information3. FAIR 
principles and methods for linking one's own data into a global distributed web of 
resources and using such a distributed web were introduced. In lectures and hands-
on sessions participants were introduced to minimal information models, Linked Data 
(RDF), ontologies, API-centric systems, and choosing identifiers for data and 
metadata, and the use of computational workflows to analyse data. OpenPHACTS 
and FAIRdom were used as examples. The course contributed to the development of 
a plan to make rare disease registries and biobanks linkable at the source and the 
                                                
2 Istituto Superiore di Sanità (http://www.iss.it/, Rome, Italy) 
3 http://biosb.nl/education/course-portfolio/course-managing-and-integrating-information-in-the-life-sciences/ 
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inclusion of interoperability criteria for evaluating registries and biobanks. These were 
presented at the ELIXIR All-Hands meeting and RD-Connect annual meeting, March, 
2016. 
The event was following the aim of delivering specific knowledge to the RD 
community to raise capacity of the participants. Participants included researchers 
representing rare disease patient registries, Elixir-SIovenia, Elixir-NL, and 
bioinformatics researchers working in academia and industry. One of the two 
coordinators is the co-lead of RD WP8 (M. Roos), while one of the tutors is 
associated with Elixir-EBI (S. Jupp). 
1.3. ELIXIR!AllJHands!Meeting!
Barcelona, 8 March 2016 
A common ELIXIR and RD-Connect workshop was organised as a special session at 
the ELIXIR All-Hands meeting in Barcelona. Agreement was reached for making the 
RD training needs survey in line with the WP11 training needs survey. Based on the 
survey results, new training courses and workshops will be prepared and offered to 
the RD community. The RD training needs survey will use the same core questions 
as the WP11 survey with possible extension for RD specifics. Key contacts for RD 
training needs were identified across RD community and it will be used for the RD 
training needs survey. 
Furthermore, key topics for the rare disease community were identified for ELIXIR 
members. These were used as requirements for tools for the community, the RD-
Connect platform, and the rare disease data linkage plan4. The topics included 
person identification, data identifiers and metadata formats, EGA data storage and 
EGA metadata and guidelines, data elements such as phenotypes and their 
descriptions, sequence-based variants and genetics information that is not sequence 
based, aggregation of patient, disease and biosample data and connecting registries 
with similar kinds of data.  
Application ontologies were discussed, the need to identify overlap in ontologies and 
mapping between ontologies, recommendable ontologies such as ORDO, HPO, 
OMIM and SNOMED-CT, the difficulties of ontology use by clinicians, tools to go 
from human readable to machine readable terms (e.g. Zooma), and tools that make 
use of harmonized annotation such as look-up systems, match-making, beacons and 
FAIR data points. 
Constraints of moving from local installations to international collaborations, 
sustainability, visibility, and scalability were discussed, as well as who from the RD 
community defines the requirements for infrastructure and tools, and how to address 
alignment with other infrastructures such as BBMRI. A survey for tools and resources 
will help to establish computing needs for benchmarking. For example benchmarking 
of negative cases is unresolved. 
Possible implementation study suggestions were discussed, such as for finding 
registries that promote retrospective harmonization, and candidate use cases and 
driving questions (e.g. eligibility for a clinical trials). 
The event was following the aims of identifying key training contacts and specific 
training needs in the RD community and delivered specific knowledge to the RD 
community to raise capacity of the participants. 
                                                
4 https://goo.gl/ujOamD  
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1.4. Variant!Analysis!Workshop!
Helsinki, 13–15 June 2016 
 
This workshop, which is part of the ELIXIR Train-the-researcher workshop series,  
covered several aspects of variant analysis including annotation and prioritization. 
The course consisted of three independent days, which participants could combine 
according to their needs. Each course day contained both lectures and hands-on 
exercises, which were suitable for everybody as analysis was performed with easy-
to-use graphical tools. This course was organized by the ELIXIR EXCELERATE 
project together with RD-Connect. The website of the course is 
https://www.csc.fi/web/training/-/variant-analysis and most of the sessions were 
recorded on video and have been made available through youtube: 
https://www.youtube.com/playlist?list=PLjiXAZO27elCDh3RrkpmnQLfLuyIqL2Bz 
The programme and summary of the sessions was: 
 
Introduction to variant analysis from sequencing data (13 June 2016) 
(Maria Lehtivaara and Eija Korpelainen (CSC)) 
This introductory day covered variant analysis from raw sequence reads to variant 
annotation, introducing the theory, analysis tools and file formats involved. The 
program consisted of alternating short lectures and hands-on exercises. As the user-
friendly Chipster software was used in the exercises, no previous knowledge of Unix 
or R was required and the tutorial was thus suitable for everybody. The following 
topics and analysis tools were covered: 
● quality control (FastQC, PRINSEQ) 
● preprocessing (Trimmomatic) 
● alignment (BWA) 
● alignment level QC (Samtools) 
● marking duplicates (Picard) 
● calling and filtering variants (Samtools, BCFtools, VCFtools) 
● variant annotation (VEP) 
● visualizing variants in genomic context (Chipster genome browser using 
Ensembl data) 
 
Variant annotation and effect prediction (14 June 2016) 
Session 1: Protein structure analysis of mutations using HOPE (Hanka Venselaar, 
CMBI, Radboudumc) 
HOPE is an automatic mutant analysis server that can provide insight into the 
structural effects of a mutation. It is aimed at users in the biomedical field who wish 
to visualize and understand their mutation of interest. Given a sequence and 
mutation, HOPE will show the effect of that mutation in such a way that also those 
without a bioinformatics background can understand it.  
Session 2: Ensembl: Analysing variation data with the Variant Effect Predictor 
(Benjamin Moore, EBI) 
EXCELERATE Deliverable 8.3: Annex I 
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The Ensembl project provides a comprehensive and integrated source of annotation 
of mainly vertebrate genome sequences. The session began with an introduction to 
the Ensembl project, gene model annotations and variation data followed by hands-
on demonstrations and exercises focused on viewing the range of variation data 
available in Ensembl. We also explored how BioMart can be used as a flexible tool 
for accessing and downloading a variety of different types of variation data from 
Ensembl. 
The second part of the session covered the Variant Effect Predictor (VEP) in detail 
and how this tool can be used to analyse variation data. VEP determines the effect of 
variants (SNPs, insertions, deletions, CNVs or structural variants) on genes, 
transcripts, and protein sequence, as well as regulatory regions. Given the 
coordinates and nucleotide changes, it reports the genes and transcripts affected 
and the location of the variants (e.g. upstream of a transcript, in coding sequence, in 
non-coding RNA, in regulatory regions). It also reports for example the consequence 
of the variants on the protein sequence (e.g. stop gained, missense, stop lost, 
frameshift) and SIFT and PolyPhen scores for the changes. The hands-on 
demonstrations and exercises first used the VEP web interface (this part is suitable 
for everybody), followed by VEP use via the standalone Perl script and REST API 
(this part was suitable for participants with coding experience).  
Audience: This course was aimed at wet-lab researchers, clinicians and 
bioinformaticians who wanted to get hands-on experience using Ensembl to analyse 
variation data. 
Learning outcomes 
● Learn how to view variation data in the Ensembl browser 
● Learn how to analyse your own variation data with the Variant Effect Predictor 
(VEP) 
 
Variant analysis and prioritization (15 June 2016) 
Session 1: European Genome-phenome Archive (Ilkka Lappalainen, CSC) 
The European Genome-phenome Archive (EGA) is a permanent archive that 
promotes the distribution and sharing of genetic and phenotypic data consented for 
specific approved uses but not fully open, public distribution. The EGA follows strict 
protocols for information management, data storage, security and dissemination. 
Authorized access to the data is managed in partnership with the data-providing 
organizations. The EGA includes major reference data collections for human 
genetics research. 
Session 2: RD-Connect genomics analysis platform (Sergi Beltran, Centro Nacional 
de Análisis Genómico)  
The RD-Connect genomics analysis platform connects databases, registries, 
biobanks and clinical bioinformatics for rare disease research. The genomics side of 
the platform already includes hundreds of exomes linked to detailed phenotypes 
stored in PhenoTips using the Human Phenotype Ontology. Exomes have been 
processed with the RD-Connect standard analysis pipeline for genomics, which 
exceeds 99% precision and sensitivity when compared to the National Institute of 
Standards and Technology (NIST) reference set of calls for NA12878. The exomes 
can be combined in a very flexible manner and variants can be filtered and prioritized 
through the user-friendly interface using the most common quality, genomic location, 
effect, pathogenicity and population frequency annotations, including CADD and 
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ExAC. In this session we learned what is the submission workflow to the RD-Connect 
platform and how one can access and analyse their data. The hands-on part allowed 
to try the genomics analysis platform. 
Session 3: Variant prioritization with UMD-Predictor, VarAFT and Human Splicing 
Finder (David Salgado, Aix Marseille Universite) 
Sequencing generates huge amount of variants. Even after quality checks thousands 
of variants need to be prioritized to highlight potential causative mutations, often 
limited to one or two mutations depending on the mode of inheritance. This session 
covered the following systems which help with these tasks: 
● UMD-Predictor, a pathogenicity prediction system for any human cDNA 
substitution leading to synonymous, missense or nonsense amino acid 
change. 
● Human Splice Finder a pathogenicity prediction system for any intronic/exonic 
mutations that could impact splicing signals.  
● VarAFT, a prioritization system to analyse and filter variations from NGS data. 
During this training session, participants were introduced to these systems and used 
UMD-Predictor and VarAFT on real use-cases. 
Session 4: Genome variant annotation and interpretation in a clinical context using 
omnomicsNGS (Christophe Roos, Euformatics) 
omnomicsNGS is a CE-marked software platform for clinical reporting on patient 
NGS data. It provides relevant genomic and mutation information for clinicians and 
molecular genetics laboratories based on patient data and external information 
sources. It can be tailored to report on markers in specific gene panels and it can 
also be used for analyses on rare genetic diseases using whole exome sequence 
data. 
1.5. Next!generation!registries:!going!FAIR,!going!Gold!
Rome, 27–29 July 2016 
 
The main aim of this workshop was to align on next steps towards interoperable rare 
disease patient/disease registries between different representatives from the rare 
disease domain: patients, biobanks, registries, catalogues, software solution 
providers, and infrastructures (e.g. ELIXIR, BBMRI). The official report is due in 
September. Here, we summarize highlights. Consensus was reached on continued 
involvement with GA4GH and IRDIRC task forces on patient identifiers and practical 
computable ELSI, and task forces that address sustainability. Consensus was also 
reached (or confirmed) for the use of ontologies + Linked Data + FAIR data point 
APIs to implement the interoperability principle of the FAIR data principles for the 
rare disease domain. Four software solution providers agreed to collaborate on 
implementing support for FAIR principles in their tools based on recommendations 
from the rare disease community (which in turn works within ELIXIR to adopt FAIR 
principles). 
The workshop was organised by partners in RD-Connect, particularly the Istituto 
Superiore di Sanità (http://www.iss.it/, Italy), with contributions from ELIXIR, a rare 
disease patient representative, RD-Connect and RaDiCo representatives for 
biobanks, registries and cohort studies, Orphanet, and software solution providers for 
patient/disease registries including PatientCrossroads 
(https://www.patientcrossroads.com/, USA), OSSE (https://www.osse-register.de, 
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Germany), RDRF (https://muccg.github.io/rdrf/, Australia), and the developers of ID-
Cards, a registry of patient/disease registries and biobanks (http://catalogue.rd-
connect.eu/, Austria). 
The event was following the aim of delivering specific knowledge to the RD 
community to raise capacity of the participants. 
2. Future!events!
A number of future training events are planned that will further enable establishment 
and more optimal maintenance of rare disease registries through specific f2f and e-
learning courses with the help of WP11 and widespread and scaled up with the help 
of WP10. 
2.1. RDJConnect!and!ELIXIR!4th!International!Summer!
School!on!RD!and!Orphan!Drug!Registries!and!RDJ
Connect!BYOD!Workshop!to!Link!RD!Registries5!
26–30 September 2016 
 
This event will be organised with the help of the External Relations Office, Istituto 
Superiore di Sanità. The event is open to health professionals, researchers, 
clinicians and representatives of patient associations engaged in rare disease patient 
registries. With the use of Problem-Based Learning methodology, where a problem 
serves as a didactic stimulus, the attendees will be introduced to the aims and needs 
of clinical research registries. The course covers: (i) resources needed to establish a 
clinical research registry; (ii) registry sustainability, including registry purposes, data 
and sharing, dissemination activities and the role of patient associations; (iii) the 
main steps for planning a registry and controlling its operation. The workshop 
consists of two parts: 
a. 4th International Summer School on Rare Disease and Orphan Drug 
Registries (26 – 28 September 2016) endorsed by ICORD (http://icord.org/). 
The training will use Problem-Based Learning. Scientific articles, expert 
lectures, consultations and feedback to support the attendees in solving the 
problem. http://www.iss.it/cnmr/?lang=1&id=2662&tipo=3 
b. RD-Connect BYOD Workshop to Link Rare Disease Registries (29 – 30 
September 2016 in Rome) will be a hands-on experience, where the 
attendees work with FAIR data experts to make their (sample) data FAIR with 
a focus on interoperability, and link them to existing FAIR data. The event is 
co-organised by RD-Connect, ISS-CNMR, ELIXIR (https://www.elixir-
europe.org/) and DTL(http://www.dtls.nl/), 
http://www.iss.it/cnmr/?lang=1&id=2662&tipo=3 
 
                                                
5 http://www.iss.it/cnmr/?lang=1&id=2662&tipo=3  
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2.2. RD!training!needs!survey!
Until the end of 2016 the survey on RD training needs will be executed and analysed. 
There was a short delay in its execution, pending the WP11 general training needs 
survey to be finalised so that we can have the same and comparable core of 
questions. This will also allow us to make a reliable comparison of results between 
general training needs in life science information and RD community training needs. 
Based on the results of the survey a new course/workshop will be prepared in the 
first half of 2017 and where possible aligned with events in the rare disease domain 
throughout 2017. The courses/workshops will use e-learning and other training 
techniques successfully tested in the ELIXIR training platform within WP11 Train the 
Researcher (TtR) and Train the Trainer (TtT) subtasks. All course materials will also 
be available for RD-Connect. 
2.3. Bring!your!own!data!workshops!for!registry!software!
solution!providers!and!molecular!data!
Based on earlier assessments of requirements and gaps in the rare disease domain, 
two BYODs are in preparation. A BYOD for patient registry software solution 
providers addresses the issue that patient and disease registries are typically 
developed by third party software developers for rare disease specialists. Having 
support for FAIR data built into the software will increase the interoperability of the 
resulting registries. The second BYOD addresses the goal to enable linking data at 
the level of phenotypes to data at the level of molecular processes. Each BYOD is 
treated as part of an implementation study and is coordinated via the overarching, 
cross-project data linkage plan through which also the specific rare disease areas 
and use cases are defined.   
 
3. References!
● Slides RD-CONNECT WORKSHOP 24 - 25 September 2015 
http://www.iss.it/binary/cnmr4/cont/Slide1.zip 
● 3rd International SummerSchool 2015 speakers slide presentations 
http://www.iss.it/binary/cnmr4/cont/3rd_International_SummerSchool_2015_s
peakers_slide_presentations.zip 
● Data linkage and tutorial RD-CONNECT WORKSHOP 24 - 25 September 
2015 
http://www.iss.it/binary/cnmr4/cont/RD_Connect_workshop_data_linkage_an
d_Tutorial.zip 
 
